Exelixis (EX9) Financial Statements
Exelixis Financial Overview
Exelixis's market cap is currently $15.16B. The company's EPS TTM is $3.45; its P/E ratio is 20.11; Exelixis is estimated to report earnings on February 9, 2027, and the estimated EPS forecast is $0.86. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.32B | $ 2.17B | $ 1.83B | $ 1.61B | $ 1.43B |
| Gross Profit | $ 2.24B | $ 2.09B | $ 1.76B | $ 1.55B | $ 1.38B |
| Operating Income | $ 872.19M | $ 604.62M | $ 170.88M | $ 201.48M | $ 286.67M |
| EBITDA | $ 921.76M | $ 718.75M | $ 283.24M | $ 255.23M | $ 307.78M |
| Net Income | $ 782.57M | $ 521.27M | $ 207.76M | $ 182.28M | $ 231.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.06B | $ 1.11B | $ 995.30M | $ 1.31B | $ 1.47B |
| Total Assets | $ 2.84B | $ 2.95B | $ 2.94B | $ 3.07B | $ 2.62B |
| Total Debt | $ 173.04M | $ 190.82M | $ 189.94M | $ 190.17M | $ 51.27M |
| Net Debt | $ -309.45M | $ -26.55M | $ -73.05M | $ -311.02M | $ -595.90M |
| Total Liabilities | $ 683.10M | $ 703.49M | $ 678.45M | $ 583.06M | $ 405.62M |
| Stockholders' Equity | $ 2.16B | $ 2.24B | $ 2.26B | $ 2.49B | $ 2.21B |
| Cash Flow | |||||
| Free Cash Flow | $ 844.34M | $ 633.79M | $ 170.35M | $ 224.16M | $ 336.58M |
| Operating Cash Flow | $ 884.27M | $ 699.97M | $ 333.32M | $ 362.61M | $ 400.80M |
| Investing Cash Flow | $ 350.44M | $ -116.78M | $ -26.95M | $ -524.41M | $ -42.88M |
| Financing Cash Flow | $ -969.59M | $ -628.81M | $ -546.05M | $ 586.00K | $ -14.80M |
Currency in USD
